• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动态 pH 监测的异常 GERD 参数可预测非心源性胸痛的治疗成功。

Abnormal GERD parameters on ambulatory pH monitoring predict therapeutic success in noncardiac chest pain.

机构信息

Division of Gastroenterology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

出版信息

Am J Gastroenterol. 2010 May;105(5):1032-8. doi: 10.1038/ajg.2009.646. Epub 2009 Nov 17.

DOI:10.1038/ajg.2009.646
PMID:19920808
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3835753/
Abstract

OBJECTIVES

The value of gastroesophageal reflux disease (GERD) indicators (acid exposure time (AET), symptom association probability (SAP), and symptom index (SI)) in predicting therapeutic success in noncardiac chest pain (NCCP) has not been systematically evaluated in outcome studies.

METHODS

We retrospectively identified 98 subjects with NCCP (age 51.8+/-1.2 years, 75 women, mean duration of symptoms 7.3+/-0.4 years) who underwent pH monitoring off antireflux therapy. Distal esophageal AET (abnormal if > or = 4.0%), SAP (measured as Ghillibert probability estimate, abnormal if P<0.05), and SI (abnormal if > or = 50%) were calculated; symptom severity and change after therapy were assessed on a 10-point Likert scale. Subjects were interviewed 2.8+/-0.9 years after the pH study to determine the degree of symptom change (high-degree response (HDR), with definite, sustained symptom improvement) after antireflux therapy. Regression analysis was used to determine the independent predictors of HDR.

RESULTS

GERD indicators were present in 61 subjects (62.2%); 52 subjects (53.1%) had abnormal AET, 26 (26.5%) had positive SAP, and 25 (25.5%) had positive SI. With therapy, mean symptom scores improved from 6.3+/-0.3 at the time of the pH study to 2.9+/-0.3 at the time of interview (P<0.001). A total of 58 subjects (59.2%) achieved HDR, and another 29.6% had moderate symptom improvement. On univariate analysis, HDR was associated with positive SAP (P=0.003) and elevated AET (P=0.015) but not with demographics, SI, or esophageal motor pattern. In regression analysis containing demographics, GERD indicators, psychiatric comorbidity, and esophageal motor pattern, positive SAP was retained as a significant predictor of HDR (P=0.003); elevated AET trended toward significance (P=0.055). Frequency of HDR was highest when subjects had all three GERD parameters abnormal (93.3% HDR) or both elevated AET and positive SAP (88.2% HDR, P<0.001 compared with only one or no GERD parameter abnormal).

CONCLUSIONS

Positive statistical tests of symptom association predict the therapeutic success of GERD management in NCCP. When used hierarchically, response to antireflux therapy is best predicted when GERD parameters are all abnormal and poorest when parameters are normal. These results support the importance of GERD, the relevance of symptom association testing during ambulatory pH monitoring, and the value of intensive antireflux therapy in NCCP.

摘要

目的

胃食管反流病(GERD)指标(酸暴露时间(AET)、症状关联概率(SAP)和症状指数(SI))在预测非心源性胸痛(NCCP)治疗成功中的价值尚未在结局研究中得到系统评价。

方法

我们回顾性地确定了 98 例 NCCP 患者(年龄 51.8+/-1.2 岁,75 名女性,症状平均持续时间 7.3+/-0.4 年),这些患者在接受抗反流治疗前进行了 pH 监测。计算远端食管 AET(异常如果>或=4.0%)、SAP(以 Ghillibert 概率估计测量,异常如果 P<0.05)和 SI(异常如果>或=50%);在 10 分制量表上评估治疗前后的症状严重程度和变化。在 pH 研究后 2.8+/-0.9 年对受试者进行访谈,以确定抗反流治疗后症状变化的程度(高反应度(HDR),症状有明确、持续改善)。回归分析用于确定 HDR 的独立预测因素。

结果

61 例(62.2%)存在 GERD 指标;52 例(53.1%)AET 异常,26 例(26.5%)SAP 阳性,25 例(25.5%)SI 阳性。经过治疗,平均症状评分从 pH 研究时的 6.3+/-0.3 分改善至访谈时的 2.9+/-0.3 分(P<0.001)。共有 58 例(59.2%)达到 HDR,另有 29.6%有中度症状改善。单因素分析显示,HDR 与 SAP 阳性(P=0.003)和 AET 升高(P=0.015)相关,但与人口统计学、SI 或食管动力模式无关。在包含人口统计学、GERD 指标、精神共病和食管动力模式的回归分析中,SAP 阳性被保留为 HDR 的显著预测因素(P=0.003);AET 升高呈显著趋势(P=0.055)。当受试者的所有三种 GERD 参数异常(93.3% HDR)或 AET 升高和 SAP 阳性时,HDR 的频率最高(88.2% HDR,与仅一个或没有 GERD 参数异常相比,P<0.001)。

结论

症状关联的阳性统计检验预测了 NCCP 中 GERD 管理的治疗成功。当按层次使用时,当 GERD 参数全部异常时,对反流治疗的反应最佳,而当参数正常时最差。这些结果支持 GERD 的重要性、动态 pH 监测期间症状关联测试的相关性以及 NCCP 中强化抗反流治疗的价值。

相似文献

1
Abnormal GERD parameters on ambulatory pH monitoring predict therapeutic success in noncardiac chest pain.动态 pH 监测的异常 GERD 参数可预测非心源性胸痛的治疗成功。
Am J Gastroenterol. 2010 May;105(5):1032-8. doi: 10.1038/ajg.2009.646. Epub 2009 Nov 17.
2
Long-term therapeutic outcome of patients undergoing ambulatory pH monitoring for chronic unexplained cough.慢性不明原因咳嗽患者行门诊 pH 监测的长期治疗效果。
J Clin Gastroenterol. 2010 Apr;44(4):254-60. doi: 10.1097/MCG.0b013e3181b8e97b.
3
The effect of antisecretory therapy and study duration on ambulatory esophageal pH monitoring.抗分泌治疗和研究持续时间对食管 pH 监测的影响。
Dig Dis Sci. 2011 May;56(5):1412-9. doi: 10.1007/s10620-010-1443-7. Epub 2010 Nov 3.
4
[Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].[胃食管反流病相关非心源性胸痛的诊断]
Zhonghua Yi Xue Za Zhi. 2008 May 27;88(20):1390-3.
5
[What is the utility of proton pump inhibitor testing in non-cardiac chest pain?].[质子泵抑制剂检测在非心源性胸痛中的作用是什么?]
Gastroenterol Hepatol. 2014 Oct;37(8):452-61. doi: 10.1016/j.gastrohep.2014.02.009. Epub 2014 Apr 13.
6
Parameters on esophageal pH-impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease.食管pH-阻抗监测中预测胃食管反流病患者预后的参数。
Clin Gastroenterol Hepatol. 2015 May;13(5):884-91. doi: 10.1016/j.cgh.2014.08.029. Epub 2014 Aug 23.
7
Evaluation of symptom index in identifying gastroesophageal reflux disease-related noncardiac chest pain.评估症状指数在识别胃食管反流病相关性非心源性胸痛中的作用。
J Clin Gastroenterol. 2004 Jan;38(1):24-9. doi: 10.1097/00004836-200401000-00007.
8
Correlation of ambulatory 24-hour esophageal pH monitoring results with symptom improvement in patients with noncardiac chest pain due to gastroesophageal reflux disease.非心源性胸痛的胃食管反流病患者动态24小时食管pH监测结果与症状改善的相关性
J Clin Gastroenterol. 1999 Jan;28(1):36-9. doi: 10.1097/00004836-199901000-00008.
9
GERD phenotypes from pH-impedance monitoring predict symptomatic outcomes on prospective evaluation.pH阻抗监测得出的胃食管反流病表型可预测前瞻性评估中的症状结局。
Neurogastroenterol Motil. 2016 Apr;28(4):513-21. doi: 10.1111/nmo.12745. Epub 2015 Dec 20.
10
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?质子泵抑制剂反应者,经阻抗和 pH 监测未被确认为 GERD 患者:他们是谁?
Neurogastroenterol Motil. 2014 Jan;26(1):28-35. doi: 10.1111/nmo.12221. Epub 2013 Aug 29.

引用本文的文献

1
Diagnosis and Management of Noncardiac Chest Pain.非心源性胸痛的诊断与管理
Gastroenterol Hepatol (N Y). 2024 Oct;20(9):533-541.
2
Latin American consensus on diagnosis of gastroesophageal reflux disease.拉丁美洲胃食管反流病诊断共识。
Neurogastroenterol Motil. 2024 Mar;36(3):e14735. doi: 10.1111/nmo.14735. Epub 2024 Jan 15.
3
2020 Seoul Consensus on the Diagnosis and Management of Gastroesophageal Reflux Disease.《2020年胃食管反流病诊断与管理首尔共识》

本文引用的文献

1
Long-term therapeutic outcome of patients undergoing ambulatory pH monitoring for chronic unexplained cough.慢性不明原因咳嗽患者行门诊 pH 监测的长期治疗效果。
J Clin Gastroenterol. 2010 Apr;44(4):254-60. doi: 10.1097/MCG.0b013e3181b8e97b.
2
Esophageal-reflux monitoring.食管反流监测
Gastrointest Endosc. 2009 Apr;69(4):917-30, 930.e1. doi: 10.1016/j.gie.2008.09.022. Epub 2009 Feb 26.
3
Noncardiac chest pain-treatment approaches.非心源性胸痛的治疗方法。
J Neurogastroenterol Motil. 2021 Oct 30;27(4):453-481. doi: 10.5056/jnm21077.
4
Extra-Esophageal Presentation of Gastroesophageal Reflux Disease: 2020 Update.胃食管反流病的食管外表现:2020年更新
J Clin Med. 2020 Aug 7;9(8):2559. doi: 10.3390/jcm9082559.
5
A budget impact analysis of a magnetic sphincter augmentation device for the treatment of medication-refractory mechanical gastroesophageal reflux disease: a United States payer perspective.一种磁括约肌增强装置治疗药物难治性机械性胃食管反流病的预算影响分析:美国支付者视角。
Surg Endosc. 2020 Apr;34(4):1561-1572. doi: 10.1007/s00464-019-06916-6. Epub 2019 Sep 26.
6
Magnetic sphincter augmentation: Optimal patient selection and referral care pathways.磁括约肌增强术:最佳患者选择及转诊护理路径
World J Gastrointest Endosc. 2019 Aug 16;11(8):472-476. doi: 10.4253/wjge.v11.i8.472.
7
The role of oesophageal physiological testing in the assessment of noncardiac chest pain.食管生理测试在非心源性胸痛评估中的作用。
Ther Adv Chronic Dis. 2018 Sep 11;9(12):257-267. doi: 10.1177/2040622318791392. eCollection 2018.
8
Modern diagnosis of GERD: the Lyon Consensus.现代 GERD 诊断:里昂共识。
Gut. 2018 Jul;67(7):1351-1362. doi: 10.1136/gutjnl-2017-314722. Epub 2018 Feb 3.
9
Determinants of the Association between Non-Cardiac Chest Pain and Reflux.非心源性胸痛与反流之间关联的决定因素
Am J Gastroenterol. 2017 Nov;112(11):1671-1677. doi: 10.1038/ajg.2017.288. Epub 2017 Oct 10.
10
Expert consensus document: Advances in the physiological assessment and diagnosis of GERD.专家共识文件:胃食管反流病生理学评估和诊断的进展。
Nat Rev Gastroenterol Hepatol. 2017 Nov;14(11):665-676. doi: 10.1038/nrgastro.2017.130. Epub 2017 Sep 27.
Gastroenterol Clin North Am. 2008 Dec;37(4):859-78, ix. doi: 10.1016/j.gtc.2008.09.013.
4
The proton pump inhibitor (PPI) test in GERD: does it still have a role?质子泵抑制剂(PPI)试验在胃食管反流病(GERD)中的应用:它是否仍有作用?
J Clin Gastroenterol. 2008 Sep;42(8):867-74. doi: 10.1097/MCG.0b013e31816c47ed.
5
ACG practice guidelines: esophageal reflux testing.美国胃肠病学会实践指南:食管反流检测
Am J Gastroenterol. 2007 Mar;102(3):668-85. doi: 10.1111/j.1572-0241.2006.00936.x.
6
Nonacid reflux in patients with chronic cough on acid-suppressive therapy.接受抑酸治疗的慢性咳嗽患者中的非酸性反流
Chest. 2006 Aug;130(2):386-91. doi: 10.1378/chest.130.2.386.
7
Wireless pH monitoring in patients with non-cardiac chest pain.非心源性胸痛患者的无线pH监测
Am J Gastroenterol. 2006 Mar;101(3):446-52. doi: 10.1111/j.1572-0241.2006.00425.x.
8
Review article: the role of pH monitoring in extraoesophageal gastro-oesophageal reflux disease.综述文章:pH监测在食管外胃食管反流病中的作用
Aliment Pharmacol Ther. 2006 Mar;23 Suppl 1:40-9. doi: 10.1111/j.1365-2036.2006.02797.x.
9
Is proton pump inhibitor testing an effective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain?: a meta-analysis.质子泵抑制剂试验是诊断非心源性胸痛患者胃食管反流病的有效方法吗?一项荟萃分析。
Arch Intern Med. 2005 Jun 13;165(11):1222-8. doi: 10.1001/archinte.165.11.1222.
10
Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis.质子泵抑制剂在非心源性胸痛中的诊断和治疗应用:一项荟萃分析。
Am J Gastroenterol. 2005 Jun;100(6):1226-32. doi: 10.1111/j.1572-0241.2005.41657.x.